Propanc Biopharma, Inc. received a written notice on October 23, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market indicating that the company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) f